Jennifer Dotson
Concepts (217)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammatory Bowel Diseases | 28 | 2025 | 85 | 9.770 |
Why?
| Crohn Disease | 24 | 2025 | 117 | 6.500 |
Why?
| Colitis, Ulcerative | 12 | 2025 | 67 | 2.890 |
Why?
| Gastrointestinal Agents | 6 | 2025 | 41 | 2.180 |
Why?
| Gastroenterology | 4 | 2024 | 33 | 1.590 |
Why?
| Child | 42 | 2025 | 7248 | 1.510 |
Why?
| Pediatrics | 4 | 2024 | 293 | 1.320 |
Why?
| Adolescent | 32 | 2025 | 6739 | 1.270 |
Why?
| Patient Acceptance of Health Care | 2 | 2025 | 358 | 1.120 |
Why?
| Leukemia, Myeloid, Acute | 2 | 2018 | 203 | 1.040 |
Why?
| Anemia | 3 | 2022 | 74 | 1.000 |
Why?
| Accountable Care Organizations | 1 | 2025 | 6 | 0.970 |
Why?
| Anemia, Iron-Deficiency | 2 | 2022 | 24 | 0.960 |
Why?
| Tumor Necrosis Factor-alpha | 6 | 2025 | 399 | 0.900 |
Why?
| Health Care Costs | 1 | 2025 | 174 | 0.890 |
Why?
| Abdominal Abscess | 2 | 2015 | 15 | 0.880 |
Why?
| Drainage | 2 | 2015 | 87 | 0.850 |
Why?
| Humans | 57 | 2025 | 52483 | 0.850 |
Why?
| Induction Chemotherapy | 3 | 2022 | 64 | 0.830 |
Why?
| Emergency Service, Hospital | 2 | 2019 | 522 | 0.810 |
Why?
| Male | 35 | 2025 | 26761 | 0.790 |
Why?
| Healthcare Disparities | 2 | 2017 | 299 | 0.780 |
Why?
| Retrospective Studies | 25 | 2025 | 6607 | 0.760 |
Why?
| Female | 34 | 2025 | 28171 | 0.760 |
Why?
| Ambulatory Care | 2 | 2023 | 239 | 0.750 |
Why?
| Severity of Illness Index | 6 | 2017 | 1026 | 0.740 |
Why?
| Adrenal Cortex Hormones | 3 | 2022 | 116 | 0.710 |
Why?
| Transition to Adult Care | 1 | 2021 | 18 | 0.710 |
Why?
| Patient-Centered Care | 1 | 2022 | 141 | 0.700 |
Why?
| Arthralgia | 2 | 2011 | 44 | 0.690 |
Why?
| Young Adult | 16 | 2024 | 4329 | 0.690 |
Why?
| Histoplasmosis | 3 | 2024 | 47 | 0.670 |
Why?
| Enterocolitis, Neutropenic | 1 | 2018 | 6 | 0.620 |
Why?
| Staurosporine | 1 | 2018 | 13 | 0.620 |
Why?
| fms-Like Tyrosine Kinase 3 | 1 | 2018 | 20 | 0.610 |
Why?
| Biosimilar Pharmaceuticals | 3 | 2024 | 5 | 0.610 |
Why?
| Cytarabine | 1 | 2018 | 42 | 0.590 |
Why?
| Neurotoxicity Syndromes | 1 | 2018 | 46 | 0.570 |
Why?
| Insurance, Health | 1 | 2019 | 131 | 0.570 |
Why?
| Insurance Coverage | 1 | 2019 | 115 | 0.560 |
Why?
| Telemedicine | 1 | 2023 | 494 | 0.530 |
Why?
| Quality Improvement | 4 | 2020 | 226 | 0.530 |
Why?
| Socioeconomic Factors | 1 | 2019 | 610 | 0.510 |
Why?
| Child, Preschool | 11 | 2025 | 4076 | 0.500 |
Why?
| Fellowships and Scholarships | 1 | 2016 | 127 | 0.460 |
Why?
| Achievement | 1 | 2015 | 37 | 0.460 |
Why?
| Hospitalization | 3 | 2020 | 736 | 0.460 |
Why?
| Education, Medical, Graduate | 1 | 2016 | 219 | 0.440 |
Why?
| Anti-Inflammatory Agents | 2 | 2015 | 166 | 0.430 |
Why?
| Educational Measurement | 1 | 2015 | 196 | 0.420 |
Why?
| Sex Factors | 1 | 2015 | 727 | 0.410 |
Why?
| Follow-Up Studies | 6 | 2019 | 2279 | 0.400 |
Why?
| Patient Readmission | 1 | 2015 | 246 | 0.400 |
Why?
| Cross-Sectional Studies | 4 | 2025 | 1678 | 0.390 |
Why?
| United States | 8 | 2025 | 5192 | 0.390 |
Why?
| Tomography, X-Ray Computed | 4 | 2025 | 1165 | 0.370 |
Why?
| Infusions, Intravenous | 2 | 2023 | 220 | 0.350 |
Why?
| Lung Diseases, Fungal | 1 | 2011 | 20 | 0.350 |
Why?
| Histoplasma | 1 | 2011 | 24 | 0.350 |
Why?
| Fungemia | 1 | 2011 | 38 | 0.350 |
Why?
| Erythema Nodosum | 1 | 2010 | 1 | 0.350 |
Why?
| Stomatitis, Aphthous | 1 | 2010 | 2 | 0.350 |
Why?
| Adult | 12 | 2024 | 14161 | 0.340 |
Why?
| Immunosuppressive Agents | 2 | 2024 | 243 | 0.330 |
Why?
| Enteral Nutrition | 2 | 2022 | 154 | 0.320 |
Why?
| Ileum | 3 | 2025 | 88 | 0.310 |
Why?
| Antibodies, Monoclonal | 2 | 2024 | 481 | 0.310 |
Why?
| Quality of Health Care | 2 | 2022 | 187 | 0.300 |
Why?
| Testosterone Congeners | 1 | 2007 | 1 | 0.280 |
Why?
| Doping in Sports | 1 | 2007 | 2 | 0.280 |
Why?
| Attitude of Health Personnel | 2 | 2024 | 360 | 0.280 |
Why?
| Androgens | 1 | 2007 | 70 | 0.270 |
Why?
| Anabolic Agents | 1 | 2007 | 44 | 0.270 |
Why?
| Chronic Disease | 4 | 2022 | 586 | 0.270 |
Why?
| Anti-Bacterial Agents | 1 | 2013 | 807 | 0.270 |
Why?
| Blood Transfusion | 2 | 2020 | 127 | 0.270 |
Why?
| Health Care Surveys | 2 | 2019 | 177 | 0.250 |
Why?
| Drug Therapy, Combination | 2 | 2024 | 395 | 0.240 |
Why?
| Ostomy | 1 | 2024 | 5 | 0.230 |
Why?
| Travel | 1 | 2024 | 37 | 0.220 |
Why?
| Delayed Diagnosis | 1 | 2024 | 30 | 0.220 |
Why?
| Policy Making | 1 | 2024 | 33 | 0.220 |
Why?
| Patient Advocacy | 1 | 2024 | 17 | 0.220 |
Why?
| Laparoscopy | 2 | 2016 | 180 | 0.210 |
Why?
| Gastrointestinal Diseases | 1 | 2025 | 125 | 0.210 |
Why?
| Drug Monitoring | 2 | 2024 | 83 | 0.210 |
Why?
| Treatment Outcome | 9 | 2025 | 5422 | 0.210 |
Why?
| Magnetic Resonance Imaging | 2 | 2025 | 1546 | 0.210 |
Why?
| Medicaid | 1 | 2025 | 264 | 0.200 |
Why?
| Anxiety | 1 | 2025 | 300 | 0.200 |
Why?
| Patient Care Team | 1 | 2024 | 272 | 0.200 |
Why?
| Red-Cell Aplasia, Pure | 1 | 2022 | 7 | 0.190 |
Why?
| Prognosis | 2 | 2019 | 2099 | 0.190 |
Why?
| Hospitals | 1 | 2023 | 182 | 0.180 |
Why?
| Myelodysplastic Syndromes | 1 | 2022 | 86 | 0.180 |
Why?
| Iron-Dextran Complex | 1 | 2020 | 3 | 0.170 |
Why?
| Ferric Compounds | 1 | 2020 | 17 | 0.170 |
Why?
| Hematinics | 1 | 2020 | 15 | 0.170 |
Why?
| Depression | 1 | 2025 | 600 | 0.170 |
Why?
| Cohort Studies | 3 | 2025 | 1542 | 0.160 |
Why?
| Maintenance Chemotherapy | 1 | 2020 | 51 | 0.160 |
Why?
| Ohio | 1 | 2019 | 45 | 0.160 |
Why?
| Medication Adherence | 1 | 2021 | 133 | 0.160 |
Why?
| Delivery of Health Care | 1 | 2022 | 323 | 0.160 |
Why?
| Drug Administration Schedule | 1 | 2019 | 374 | 0.150 |
Why?
| Allopurinol | 1 | 2018 | 7 | 0.150 |
Why?
| Azathioprine | 1 | 2018 | 13 | 0.150 |
Why?
| Pandemics | 1 | 2023 | 585 | 0.150 |
Why?
| Endemic Diseases | 2 | 2024 | 25 | 0.140 |
Why?
| Antifungal Agents | 3 | 2024 | 347 | 0.140 |
Why?
| Nutritional Status | 1 | 2018 | 137 | 0.140 |
Why?
| Aged | 4 | 2022 | 10121 | 0.140 |
Why?
| Infant | 3 | 2025 | 3733 | 0.140 |
Why?
| Monitoring, Physiologic | 1 | 2017 | 122 | 0.140 |
Why?
| Disease Management | 2 | 2016 | 188 | 0.140 |
Why?
| Statistics, Nonparametric | 1 | 2017 | 192 | 0.130 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 509 | 0.130 |
Why?
| Chi-Square Distribution | 1 | 2017 | 288 | 0.130 |
Why?
| Feasibility Studies | 2 | 2016 | 406 | 0.130 |
Why?
| Administrative Personnel | 1 | 2016 | 14 | 0.130 |
Why?
| Body Weight | 1 | 2018 | 523 | 0.130 |
Why?
| Congresses as Topic | 1 | 2016 | 48 | 0.130 |
Why?
| Regression Analysis | 1 | 2017 | 401 | 0.130 |
Why?
| Health Plan Implementation | 1 | 2016 | 38 | 0.130 |
Why?
| Proctocolectomy, Restorative | 1 | 2015 | 10 | 0.120 |
Why?
| Sexual Maturation | 1 | 2015 | 19 | 0.120 |
Why?
| Fecal Incontinence | 1 | 2015 | 15 | 0.120 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2024 | 236 | 0.120 |
Why?
| Mentors | 1 | 2016 | 57 | 0.120 |
Why?
| Rectum | 1 | 2015 | 55 | 0.120 |
Why?
| Needs Assessment | 1 | 2016 | 140 | 0.120 |
Why?
| Mood Disorders | 1 | 2015 | 59 | 0.120 |
Why?
| Rectal Diseases | 1 | 2015 | 11 | 0.120 |
Why?
| Self Efficacy | 1 | 2016 | 134 | 0.120 |
Why?
| Career Choice | 1 | 2016 | 116 | 0.120 |
Why?
| Digestive System Surgical Procedures | 1 | 2015 | 32 | 0.120 |
Why?
| Parenting | 1 | 2016 | 107 | 0.120 |
Why?
| Family | 1 | 2016 | 176 | 0.120 |
Why?
| Vitamin D Deficiency | 1 | 2015 | 46 | 0.110 |
Why?
| Education, Medical | 1 | 2016 | 111 | 0.110 |
Why?
| Liver Diseases | 1 | 2015 | 83 | 0.110 |
Why?
| Malnutrition | 1 | 2015 | 90 | 0.110 |
Why?
| Office Visits | 1 | 2014 | 45 | 0.110 |
Why?
| Seasons | 1 | 2014 | 92 | 0.110 |
Why?
| Diagnosis, Differential | 2 | 2022 | 1046 | 0.110 |
Why?
| Data Collection | 1 | 2015 | 290 | 0.110 |
Why?
| Image Processing, Computer-Assisted | 1 | 2015 | 253 | 0.110 |
Why?
| Curriculum | 1 | 2016 | 398 | 0.100 |
Why?
| Clinical Competence | 1 | 2016 | 406 | 0.100 |
Why?
| Cost Savings | 2 | 2024 | 58 | 0.100 |
Why?
| Patient Education as Topic | 1 | 2016 | 321 | 0.100 |
Why?
| Nutrition Assessment | 1 | 2013 | 66 | 0.100 |
Why?
| Risk Factors | 2 | 2023 | 3889 | 0.090 |
Why?
| Registries | 1 | 2015 | 581 | 0.090 |
Why?
| Length of Stay | 1 | 2015 | 663 | 0.090 |
Why?
| Infant, Newborn | 1 | 2019 | 2867 | 0.090 |
Why?
| Reproducibility of Results | 1 | 2015 | 1229 | 0.090 |
Why?
| Combined Modality Therapy | 1 | 2013 | 639 | 0.090 |
Why?
| Physical Examination | 1 | 2011 | 99 | 0.090 |
Why?
| Remission Induction | 2 | 2022 | 218 | 0.080 |
Why?
| Cecum | 2 | 2022 | 61 | 0.080 |
Why?
| Referral and Consultation | 1 | 2011 | 292 | 0.080 |
Why?
| Postoperative Complications | 1 | 2015 | 1068 | 0.070 |
Why?
| History, Ancient | 1 | 2007 | 10 | 0.070 |
Why?
| History, 18th Century | 1 | 2007 | 8 | 0.070 |
Why?
| History, 19th Century | 1 | 2007 | 23 | 0.070 |
Why?
| Recurrence | 2 | 2022 | 672 | 0.070 |
Why?
| History, 20th Century | 1 | 2007 | 96 | 0.070 |
Why?
| Middle Aged | 2 | 2018 | 13028 | 0.060 |
Why?
| Review Literature as Topic | 1 | 2025 | 9 | 0.060 |
Why?
| Delphi Technique | 1 | 2025 | 63 | 0.060 |
Why?
| Prospective Studies | 1 | 2010 | 2481 | 0.060 |
Why?
| Consensus | 1 | 2025 | 181 | 0.060 |
Why?
| Constriction, Pathologic | 1 | 2023 | 91 | 0.050 |
Why?
| Immunologic Factors | 1 | 2024 | 117 | 0.050 |
Why?
| C-Reactive Protein | 1 | 2024 | 155 | 0.050 |
Why?
| Focus Groups | 1 | 2024 | 196 | 0.050 |
Why?
| Necrosis | 1 | 2023 | 176 | 0.050 |
Why?
| Biological Factors | 1 | 2022 | 12 | 0.050 |
Why?
| Methotrexate | 1 | 2022 | 77 | 0.050 |
Why?
| Transferases | 1 | 2022 | 5 | 0.050 |
Why?
| Qualitative Research | 1 | 2024 | 364 | 0.050 |
Why?
| Practice Guidelines as Topic | 1 | 2025 | 488 | 0.050 |
Why?
| Colonoscopy | 1 | 2022 | 108 | 0.050 |
Why?
| Societies, Medical | 1 | 2022 | 200 | 0.040 |
Why?
| Evidence-Based Medicine | 1 | 2022 | 261 | 0.040 |
Why?
| Diagnostic Imaging | 1 | 2022 | 181 | 0.040 |
Why?
| Disease Progression | 1 | 2023 | 871 | 0.040 |
Why?
| Body Mass Index | 1 | 2023 | 689 | 0.040 |
Why?
| Overweight | 1 | 2022 | 224 | 0.040 |
Why?
| Caregivers | 1 | 2022 | 240 | 0.040 |
Why?
| Free Radical Scavengers | 1 | 2018 | 25 | 0.040 |
Why?
| DNA | 1 | 2022 | 549 | 0.040 |
Why?
| Time Factors | 1 | 2024 | 2968 | 0.040 |
Why?
| Lung Transplantation | 1 | 2017 | 39 | 0.030 |
Why?
| Patient Safety | 1 | 2017 | 104 | 0.030 |
Why?
| Tracheostomy | 1 | 2017 | 76 | 0.030 |
Why?
| Prevalence | 1 | 2020 | 1006 | 0.030 |
Why?
| Databases, Factual | 1 | 2020 | 706 | 0.030 |
Why?
| Ileostomy | 1 | 2015 | 6 | 0.030 |
Why?
| Colonic Pouches | 1 | 2015 | 7 | 0.030 |
Why?
| Mutation | 1 | 2022 | 1347 | 0.030 |
Why?
| Anal Canal | 1 | 2015 | 27 | 0.030 |
Why?
| gamma-Glutamyltransferase | 1 | 2015 | 6 | 0.030 |
Why?
| Immune Reconstitution Inflammatory Syndrome | 1 | 2015 | 1 | 0.030 |
Why?
| Aspartate Aminotransferases | 1 | 2015 | 49 | 0.030 |
Why?
| Bilirubin | 1 | 2015 | 43 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2018 | 1378 | 0.030 |
Why?
| Self Care | 1 | 2016 | 138 | 0.030 |
Why?
| Alanine Transaminase | 1 | 2015 | 122 | 0.030 |
Why?
| Alkaline Phosphatase | 1 | 2015 | 94 | 0.030 |
Why?
| Renal Insufficiency, Chronic | 1 | 2017 | 187 | 0.030 |
Why?
| Algorithms | 1 | 2018 | 672 | 0.030 |
Why?
| Social Support | 1 | 2016 | 268 | 0.030 |
Why?
| Arthritis, Rheumatoid | 1 | 2015 | 116 | 0.030 |
Why?
| Animals | 1 | 2007 | 13505 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2015 | 3392 | 0.020 |
Why?
|
|
Dotson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|